This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Yale University, Other. Active years: 2015-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2015-2020
Title: Susan Marie Metcalfe: Innovator in Neurotherapeutics
Introduction
Susan Marie Metcalfe is a distinguished inventor based in Cambridge, GB. She has made significant contributions to the field of neurotherapeutics, holding 2 patents that focus on innovative treatments for neurodegenerative diseases and immune modulation.
Latest Patents
Her latest patents include "Neurotherapeutic nanoparticle compositions comprising leukemia inhibitory factor." This invention provides compositions and methods for treating neurodegenerative diseases and central nervous system injuries. The compositions consist of a pharmaceutically acceptable carrier solution and a plurality of biodegradable nanoparticles. These nanoparticles are designed to selectively bind to the surface of neural stem cells and incorporate factors such as leukemia inhibitory factor (LIF), brain-derived neurotrophic factor (BDNF), and glial cell-derived neurotrophic factor (GDNF). The biodegradable nanoparticles are capable of delivering these factors via controlled time release. Another notable patent is the "Immuno-modulatory composition," which modulates the immune response in mammals. This composition also utilizes biodegradable nanoparticles that selectively bind to T lymphocyte cells and vascular endothelial cells, incorporating leukemia inhibitory factor (LIF) to guide tolerogenesis in patients.
Career Highlights
Throughout her career, Susan has worked with prestigious institutions, including Yale University. Her research has focused on developing innovative solutions for complex medical challenges, particularly in the realm of neurotherapeutics.
Collaborations
One of her notable collaborators is Tarek M Fahmy, with whom she has worked on advancing her research and patent applications.
Conclusion
Susan Marie Metcalfe's contributions to neurotherapeutics and immune modulation highlight her role as a leading inventor in her field. Her innovative patents reflect her commitment to improving treatment options for patients with neurodegenerative diseases and autoimmune conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile